US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Citius Pharmaceuticals, Inc.

0.7652

-0.0282-3.55%

Post-market: 0.78880.0236+3.08%19:44 EST

Volume:735.75K

Turnover:580.03K

Market Cap:17.12M

PE:-0.23

High:0.8431

Open:0.8400

Low:0.7500

Close:0.7934

52wk High:2.97

52wk Low:0.6300

Shares:22.38M

Float Shares:18.81M

Volume Ratio:1.03

T/O Rate:3.91%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.3830

EPS(LYR):-5.9739

ROE:-47.85%

ROA:-17.68%

PB:0.21

PE(LYR):-0.13

Loading ...

Overview Company News Filings

Citius Pharmaceuticals reports first revenue of $3.9 mln

Citius Oncology Inc. posts Q1 net loss of USD 5.53 million, down 17 percent

Citius Pharma Q1 stock-based compensation expense rises to USD 3.56 million, up 97%

Citius Pharmaceuticals Q1 Basic EPS USD -0.38

THOMSON REUTERS

Citius Oncology Signs Exclusive Distribution Agreement With Uniphar for LYMPHIR in Europe

Citius Oncology Expands International Distribution of Lymphir™ to European Union Through Exclusive Agreement With Uniphar

THOMSON REUTERS

Citius Oncology Inc. Files Information Statement Detailing Authorized Corporate Actions

Citius Oncology Inc. Files Draft Information Statement Outlining Authorized Corporate Actions

Dow Gains Over 100 Points; US Jobless Claims Decline

Citius Pharma Q4 EPS $(0.11) Beats $(0.43) Estimate

Press Release: Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update

Citius Oncology posts FY cash balance of USD 3.9 million and accumulated deficit of USD 64.0 million

Citius Oncology Announces Warrant and Share Issuance in $18 Million Offering

Citius Oncology Sells Shares and Warrants in $18 Million Private Placement

Citius Oncology Inc - Proceeds Support Launch of Lymphir for Cutaneous T-Cell Lymphoma

THOMSON REUTERS

Citius Oncology Inc - to Purchase 1,284,404 Shares of Common Stock at $1.09 per Share in Direct Offering

THOMSON REUTERS

BRIEF-Citius Oncology Expands Lymphir Distribution To Turkey And Middle East Countries

Citius Oncology Expands Lymphir™ Distribution to Turkey and Middle East Countries Through Exclusive Agreement With Er-Kim

THOMSON REUTERS

Citius Pharmaceuticals Highlights Oncology Pipeline and LYMPHIR Launch in New Corporate Presentation

Citius Oncology Announces U.S. Commercial Launch of Lymphir™, a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (Ctcl)

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CTXR/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CTXR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTXR\",,,,,undefined,":{"symbol":"CTXR","market":"US","secType":"STK","nameCN":"Citius Pharmaceuticals, Inc.","latestPrice":0.7652,"timestamp":1771016400000,"preClose":0.7934,"halted":0,"volume":735746,"hourTrading":{"tag":"盘后","latestPrice":0.7888,"preClose":0.7652,"latestTime":"19:44 EST","volume":1663,"amount":1301.3441,"timestamp":1771029852913,"change":0.0236,"changeRate":0.030842,"amplitude":0.050575},"delay":0,"changeRate":-0.035543231661204946,"floatShares":18810000,"shares":22376400,"eps":-3.383023,"marketStatus":"Closed President's Day","change":-0.0282,"latestTime":"02-13 16:00:00 EST","open":0.84,"high":0.8431,"low":0.75,"amount":580031.7600902,"amplitude":0.117343,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-3.383023,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771318800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.7934,"preHourTrading":{"tag":"盘前","latestPrice":0.8335,"preClose":0.7934,"latestTime":"09:22 EST","volume":36803,"amount":30782.3530664,"timestamp":1770992556018,"change":0.0401,"changeRate":0.050542,"amplitude":0.12604},"postHourTrading":{"tag":"盘后","latestPrice":0.7888,"preClose":0.7652,"latestTime":"19:44 EST","volume":1663,"amount":1301.3441,"timestamp":1771029852913,"change":0.0236,"changeRate":0.030842,"amplitude":0.050575},"volumeRatio":1.0343164862606335,"impliedVol":1.6675,"impliedVolPercentile":0.8127},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTXR\",,,,,undefined,":{"symbol":"CTXR","floatShares":18810000,"roa":"-17.68%","roe":"-47.85%","lyrEps":-5.97386,"volumeRatio":1.0343164862606335,"shares":22376400,"dividePrice":0,"high":0.8431,"amplitude":0.117343,"preClose":0.7934,"low":0.75,"week52Low":0.63,"pbRate":"0.21","psRate":"4.34","week52High":2.97,"institutionHeld":0,"latestPrice":0.7652,"eps":-3.383023,"divideRate":0,"volume":735746,"delay":0,"ttmEps":-3.383023,"open":0.84,"prevYearClose":0.777,"prevWeekClose":0.7652,"prevMonthClose":0.7401,"prevQuarterClose":0.777,"fiveDayClose":0.7547,"twentyDayClose":0.8565,"sixtyDayClose":0.9351},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CTXR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-13","symbol":"CTXR","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1770958800000,"reportTimeType":"pre","actualEps":-0.38},{"market":"US","date":"2025-12-23","symbol":"CTXR","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1766466000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-08-12","symbol":"CTXR","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.8},{"market":"US","date":"2025-05-14","symbol":"CTXR","fiscalQuarterEnding":"2025/03","expectedEps":-1.08,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-1.27},{"market":"US","date":"2025-02-14","symbol":"CTXR","fiscalQuarterEnding":"2024/12","expectedEps":-1.25,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739509200000,"reportTimeType":"post","actualEps":-1.3}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CTXR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CTXR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":2,"updateTime":1747976400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CTXR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CTXR","date":"2026-02-13","current":-0.226188,"percent":0.898374,"low":-27.197552,"twenty":-9.817891,"median":-4.715985,"eighty":-0.591511,"high":-0.165107,"avg":-5.421843,"sd":4.637121,"marketCap":16473298},"quantilePoints":[{"date":"2021-02-19","current":-12.123794,"twenty":-12.558445,"median":-3.202748,"eighty":-1.81088,"marketCap":259117287},{"date":"2021-02-26","current":-11.947234,"twenty":-12.473844,"median":-3.202748,"eighty":-1.81088,"marketCap":255343734},{"date":"2021-03-05","current":-10.534753,"twenty":-12.123794,"median":-3.2002,"eighty":-1.810735,"marketCap":225155312},{"date":"2021-03-12","current":-12.011201,"twenty":-11.976635,"median":-3.2002,"eighty":-1.810735,"marketCap":256710889},{"date":"2021-03-19","current":-12.577174,"twenty":-11.970755,"median":-3.2002,"eighty":-1.810735,"marketCap":268807214},{"date":"2021-03-26","current":-11.948315,"twenty":-11.965307,"median":-3.202748,"eighty":-1.81088,"marketCap":255366853},{"date":"2021-04-01","current":-11.571,"twenty":-11.895133,"median":-3.202748,"eighty":-1.81088,"marketCap":247302636},{"date":"2021-04-09","current":-11.470572,"twenty":-11.821036,"median":-3.2002,"eighty":-1.810735,"marketCap":245156218},{"date":"2021-04-16","current":-10.903346,"twenty":-11.680454,"median":-3.2002,"eighty":-1.810735,"marketCap":233033108},{"date":"2021-04-23","current":-11.218471,"twenty":-11.633886,"median":-3.2002,"eighty":-1.810735,"marketCap":239768169},{"date":"2021-04-30","current":-13.865526,"twenty":-11.647006,"median":-3.202748,"eighty":-1.81088,"marketCap":296342681},{"date":"2021-05-07","current":-13.676451,"twenty":-11.647006,"median":-3.202748,"eighty":-1.81088,"marketCap":292301645},{"date":"2021-05-14","current":-12.602176,"twenty":-11.647006,"median":-3.202748,"eighty":-1.81088,"marketCap":265528936},{"date":"2021-05-21","current":-15.109751,"twenty":-11.647006,"median":-3.202748,"eighty":-1.81088,"marketCap":318363775},{"date":"2021-05-28","current":-14.659674,"twenty":-11.647006,"median":-3.202748,"eighty":-1.81088,"marketCap":308880599},{"date":"2021-06-04","current":-14.981158,"twenty":-11.647006,"median":-3.202748,"eighty":-1.81088,"marketCap":315654296},{"date":"2021-06-11","current":-16.717172,"twenty":-11.647006,"median":-3.202748,"eighty":-1.81088,"marketCap":352232262},{"date":"2021-06-18","current":-23.725524,"twenty":-11.647006,"median":-3.202748,"eighty":-1.81088,"marketCap":499898864},{"date":"2021-06-25","current":-24.561383,"twenty":-11.647006,"median":-3.202748,"eighty":-1.81088,"marketCap":517510477},{"date":"2021-07-02","current":-14.793758,"twenty":-11.647006,"median":-3.202748,"eighty":-1.81088,"marketCap":311705772},{"date":"2021-07-09","current":-15.137799,"twenty":-11.647006,"median":-3.202748,"eighty":-1.81088,"marketCap":318954743},{"date":"2021-07-16","current":-13.279978,"twenty":-11.647006,"median":-3.202748,"eighty":-1.81088,"marketCap":279810297},{"date":"2021-07-23","current":-13.142362,"twenty":-11.647006,"median":-3.202748,"eighty":-1.81088,"marketCap":276910709},{"date":"2021-07-30","current":-13.004746,"twenty":-11.647006,"median":-3.202748,"eighty":-1.81088,"marketCap":274011120},{"date":"2021-08-06","current":-12.867129,"twenty":-11.647006,"median":-3.202748,"eighty":-1.81088,"marketCap":271111532},{"date":"2021-08-13","current":-11.894438,"twenty":-11.647006,"median":-3.202748,"eighty":-1.81088,"marketCap":264222766},{"date":"2021-08-20","current":-11.631577,"twenty":-11.607346,"median":-3.202748,"eighty":-1.81088,"marketCap":258383589},{"date":"2021-08-27","current":-14.391612,"twenty":-11.607346,"median":-3.202748,"eighty":-1.81088,"marketCap":319694949},{"date":"2021-09-03","current":-13.800176,"twenty":-11.607346,"median":-3.202748,"eighty":-1.81088,"marketCap":306556800},{"date":"2021-09-10","current":-13.668746,"twenty":-11.607346,"median":-3.202748,"eighty":-1.81088,"marketCap":303637212},{"date":"2021-09-17","current":-13.668746,"twenty":-11.607346,"median":-3.202748,"eighty":-1.81088,"marketCap":303637212},{"date":"2021-09-24","current":-13.734461,"twenty":-11.607346,"median":-3.202748,"eighty":-1.81088,"marketCap":305097006},{"date":"2021-10-01","current":-13.34017,"twenty":-11.607346,"median":-3.202748,"eighty":-1.81088,"marketCap":296338240},{"date":"2021-10-08","current":-13.405886,"twenty":-11.631577,"median":-3.205296,"eighty":-1.811026,"marketCap":297798035},{"date":"2021-10-15","current":-13.734461,"twenty":-11.631577,"median":-3.205296,"eighty":-1.811026,"marketCap":305097006},{"date":"2021-10-22","current":-12.748734,"twenty":-11.631577,"median":-3.205296,"eighty":-1.811026,"marketCap":283200092},{"date":"2021-10-29","current":-12.288728,"twenty":-11.631577,"median":-3.205296,"eighty":-1.811026,"marketCap":272981532},{"date":"2021-11-05","current":-12.814449,"twenty":-11.631577,"median":-3.205296,"eighty":-1.811026,"marketCap":284659886},{"date":"2021-11-12","current":-12.025868,"twenty":-11.631577,"median":-3.205296,"eighty":-1.811026,"marketCap":267142355},{"date":"2021-11-19","current":-11.237286,"twenty":-11.546503,"median":-3.205296,"eighty":-1.811026,"marketCap":249624823},{"date":"2021-11-26","current":-11.040141,"twenty":-11.470572,"median":-3.205296,"eighty":-1.811026,"marketCap":245245440},{"date":"2021-12-03","current":-9.922984,"twenty":-11.441957,"median":-3.205296,"eighty":-1.811026,"marketCap":220428937},{"date":"2021-12-10","current":-11.368717,"twenty":-11.441957,"median":-3.205296,"eighty":-1.811026,"marketCap":252544412},{"date":"2021-12-17","current":-9.944574,"twenty":-11.362234,"median":-3.205296,"eighty":-1.811026,"marketCap":229266519},{"date":"2021-12-23","current":-10.641327,"twenty":-11.31961,"median":-3.205296,"eighty":-1.811026,"marketCap":245329778},{"date":"2021-12-31","current":-9.75455,"twenty":-11.238769,"median":-3.205296,"eighty":-1.811026,"marketCap":224885630},{"date":"2022-01-07","current":-10.071256,"twenty":-11.175994,"median":-3.207083,"eighty":-1.811171,"marketCap":232187111},{"date":"2022-01-14","current":-9.691209,"twenty":-11.105856,"median":-3.207083,"eighty":-1.811171,"marketCap":223425333},{"date":"2022-01-21","current":-9.311161,"twenty":-10.984279,"median":-3.207083,"eighty":-1.811171,"marketCap":214663556},{"date":"2022-01-28","current":-8.931114,"twenty":-10.800701,"median":-3.207083,"eighty":-1.811171,"marketCap":205901778},{"date":"2022-02-04","current":-9.564526,"twenty":-10.705998,"median":-3.207083,"eighty":-1.811171,"marketCap":220504741},{"date":"2022-02-11","current":-9.13716,"twenty":-10.5434,"median":-3.207083,"eighty":-1.811171,"marketCap":220504741},{"date":"2022-02-18","current":-9.923802,"twenty":-10.451826,"median":-3.207083,"eighty":-1.811171,"marketCap":239488593},{"date":"2022-02-25","current":-9.439714,"twenty":-10.41932,"median":-3.207083,"eighty":-1.811171,"marketCap":227806222},{"date":"2022-03-04","current":-9.197671,"twenty":-10.326921,"median":-3.207083,"eighty":-1.811171,"marketCap":221965037},{"date":"2022-03-11","current":-9.318693,"twenty":-10.219721,"median":-3.207083,"eighty":-1.811171,"marketCap":224885630},{"date":"2022-03-18","current":-10.044824,"twenty":-10.071256,"median":-3.207083,"eighty":-1.811171,"marketCap":242409185},{"date":"2022-03-25","current":-11.436577,"twenty":-10.071256,"median":-3.207083,"eighty":-1.811171,"marketCap":275996000},{"date":"2022-04-01","current":-10.952489,"twenty":-10.078072,"median":-3.207083,"eighty":-1.811171,"marketCap":264313630},{"date":"2022-04-08","current":-9.258181,"twenty":-10.071256,"median":-3.207083,"eighty":-1.811171,"marketCap":223425333},{"date":"2022-04-14","current":-9.379203,"twenty":-10.067558,"median":-3.207083,"eighty":-1.811171,"marketCap":226345926},{"date":"2022-04-22","current":-7.261319,"twenty":-9.927956,"median":-3.207083,"eighty":-1.811171,"marketCap":175235556},{"date":"2022-04-29","current":-6.11161,"twenty":-9.844724,"median":-3.207083,"eighty":-1.811171,"marketCap":147489926},{"date":"2022-05-06","current":-6.293143,"twenty":-9.764196,"median":-3.207083,"eighty":-1.811171,"marketCap":151870815},{"date":"2022-05-13","current":-4.744605,"twenty":-9.703877,"median":-3.207083,"eighty":-1.811171,"marketCap":130815244},{"date":"2022-05-20","current":-4.849016,"twenty":-9.703877,"median":-3.207083,"eighty":-1.811171,"marketCap":133693998},{"date":"2022-05-27","current":-4.902546,"twenty":-9.703877,"median":-3.207083,"eighty":-1.811171,"marketCap":135169907},{"date":"2022-06-03","current":-5.151649,"twenty":-9.703877,"median":-3.207083,"eighty":-1.811171,"marketCap":142038000},{"date":"2022-06-10","current":-5.23274,"twenty":-9.640536,"median":-3.207083,"eighty":-1.811171,"marketCap":144273783},{"date":"2022-06-17","current":-4.669874,"twenty":-9.640536,"median":-3.207083,"eighty":-1.811171,"marketCap":128754816},{"date":"2022-06-24","current":-5.177089,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":142739422},{"date":"2022-07-01","current":-4.738775,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":130654502},{"date":"2022-07-08","current":-4.967737,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":136967302},{"date":"2022-07-15","current":-4.837356,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":133372513},{"date":"2022-07-22","current":-5.210479,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":143660039},{"date":"2022-07-29","current":-4.732945,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":130493759},{"date":"2022-08-05","current":-5.30005,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":146129630},{"date":"2022-08-12","current":-5.585303,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":170971667},{"date":"2022-08-19","current":-5.633041,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":172432963},{"date":"2022-08-26","current":-5.823991,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":178278148},{"date":"2022-09-02","current":-6.205892,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":189968519},{"date":"2022-09-09","current":-6.301368,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":192891111},{"date":"2022-09-16","current":-5.967204,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":182662037},{"date":"2022-09-23","current":-5.633041,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":172432963},{"date":"2022-09-30","current":-5.776254,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":176816852},{"date":"2022-10-07","current":-5.489828,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":168049074},{"date":"2022-10-14","current":-5.155665,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":157820000},{"date":"2022-10-21","current":-5.012452,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":153436111},{"date":"2022-10-28","current":-5.346615,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":163665185},{"date":"2022-11-04","current":-4.869239,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":149052222},{"date":"2022-11-11","current":-5.203402,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":159281296},{"date":"2022-11-18","current":-5.298877,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":162203889},{"date":"2022-11-25","current":-5.680778,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":173894259},{"date":"2022-12-02","current":-5.871729,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":179739444},{"date":"2022-12-09","current":-5.394353,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":165126481},{"date":"2022-12-16","current":-5.346615,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":163665185},{"date":"2022-12-23","current":-3.634346,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":122261746},{"date":"2022-12-30","current":-3.433549,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":115506792},{"date":"2023-01-06","current":-3.814716,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":128329508},{"date":"2023-01-13","current":-4.867816,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":163756465},{"date":"2023-01-20","current":-5.997844,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":201771359},{"date":"2023-01-27","current":-5.737069,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":192998691},{"date":"2023-02-03","current":-5.910919,"twenty":-9.653204,"median":-3.205296,"eighty":-1.811026,"marketCap":198847136},{"date":"2023-02-10","current":-7.310521,"twenty":-9.653204,"median":-3.208869,"eighty":-1.811026,"marketCap":204760915},{"date":"2023-02-17","current":-6.370597,"twenty":-9.653204,"median":-3.223813,"eighty":-1.811026,"marketCap":178434512},{"date":"2023-02-24","current":-5.952853,"twenty":-9.653204,"median":-3.233883,"eighty":-1.811026,"marketCap":166733888},{"date":"2023-03-03","current":-5.587327,"twenty":-9.653204,"median":-3.280986,"eighty":-1.811026,"marketCap":156495842},{"date":"2023-03-10","current":-5.587327,"twenty":-9.653204,"median":-3.280986,"eighty":-1.811026,"marketCap":156495842},{"date":"2023-03-17","current":-5.326237,"twenty":-9.653204,"median":-3.313471,"eighty":-1.811026,"marketCap":149182952},{"date":"2023-03-24","current":-5.378455,"twenty":-9.653204,"median":-3.357154,"eighty":-1.811026,"marketCap":150645530},{"date":"2023-03-31","current":-6.109507,"twenty":-9.640536,"median":-3.378441,"eighty":-1.811171,"marketCap":171121622},{"date":"2023-04-06","current":-6.840559,"twenty":-9.640536,"median":-3.389456,"eighty":-1.811171,"marketCap":191597714},{"date":"2023-04-14","current":-8.041574,"twenty":-9.653204,"median":-3.410926,"eighty":-1.811026,"marketCap":225237007},{"date":"2023-04-21","current":-7.206085,"twenty":-9.665873,"median":-3.420496,"eighty":-1.81088,"marketCap":201835759},{"date":"2023-04-28","current":-7.88492,"twenty":-9.665873,"median":-3.447789,"eighty":-1.81088,"marketCap":220849273},{"date":"2023-05-05","current":-6.527251,"twenty":-9.665873,"median":-3.475896,"eighty":-1.81088,"marketCap":182822246},{"date":"2023-05-12","current":-7.486585,"twenty":-9.665873,"median":-3.475896,"eighty":-1.81088,"marketCap":209692293},{"date":"2023-05-19","current":-5.795476,"twenty":-9.665873,"median":-3.489928,"eighty":-1.81088,"marketCap":179509311},{"date":"2023-05-26","current":-5.539039,"twenty":-9.665873,"median":-3.508381,"eighty":-1.81088,"marketCap":171566421},{"date":"2023-06-02","current":-6.359637,"twenty":-9.665873,"median":-3.553285,"eighty":-1.81088,"marketCap":196983669},{"date":"2023-06-09","current":-6.410925,"twenty":-9.665873,"median":-3.582339,"eighty":-1.81088,"marketCap":198572247},{"date":"2023-06-16","current":-6.462212,"twenty":-9.665873,"median":-3.60818,"eighty":-1.81088,"marketCap":200160825},{"date":"2023-06-23","current":-6.667362,"twenty":-9.678541,"median":-3.634346,"eighty":-1.810735,"marketCap":206515137},{"date":"2023-06-30","current":-6.051913,"twenty":-9.691209,"median":-3.701415,"eighty":-1.811316,"marketCap":187452201},{"date":"2023-07-07","current":-5.795476,"twenty":-9.691209,"median":-3.735776,"eighty":-1.811316,"marketCap":179509311},{"date":"2023-07-14","current":-6.205775,"twenty":-9.691209,"median":-3.768261,"eighty":-1.811316,"marketCap":192217935},{"date":"2023-07-21","current":-6.1032,"twenty":-9.691209,"median":-3.823974,"eighty":-1.811316,"marketCap":189040779},{"date":"2023-07-28","current":-5.590326,"twenty":-9.691209,"median":-3.91285,"eighty":-1.811316,"marketCap":173154999},{"date":"2023-08-04","current":-5.014882,"twenty":-9.691209,"median":-3.990579,"eighty":-1.814272,"marketCap":155331154},{"date":"2023-08-11","current":-5.110276,"twenty":-9.691209,"median":-4.1286,"eighty":-1.819509,"marketCap":158285909},{"date":"2023-08-18","current":-4.631271,"twenty":-9.691209,"median":-4.491834,"eighty":-1.824794,"marketCap":141669384},{"date":"2023-08-25","current":-4.641657,"twenty":-9.691209,"median":-4.679028,"eighty":-1.837347,"marketCap":141987099},{"date":"2023-09-01","current":-4.737212,"twenty":-9.691209,"median":-4.711745,"eighty":-1.837347,"marketCap":144910083},{"date":"2023-09-08","current":-4.545584,"twenty":-9.691209,"median":-4.715455,"eighty":-1.837347,"marketCap":139048230},{"date":"2023-09-15","current":-3.945772,"twenty":-9.691209,"median":-4.715455,"eighty":-1.846623,"marketCap":120700154},{"date":"2023-09-22","current":-3.591079,"twenty":-9.691209,"median":-4.715455,"eighty":-1.855185,"marketCap":109850167},{"date":"2023-09-29","current":-3.593156,"twenty":-9.691209,"median":-4.715455,"eighty":-1.855185,"marketCap":109913710},{"date":"2023-10-06","current":-3.474232,"twenty":-9.691209,"median":-4.715455,"eighty":-1.855185,"marketCap":106275866},{"date":"2023-10-13","current":-3.791535,"twenty":-9.691209,"median":-4.715455,"eighty":-1.855185,"marketCap":115982078},{"date":"2023-10-20","current":-3.663783,"twenty":-9.691209,"median":-4.715455,"eighty":-1.855185,"marketCap":112074176},{"date":"2023-10-27","current":-3.905265,"twenty":-9.691209,"median":-4.717575,"eighty":-1.855177,"marketCap":119461064},{"date":"2023-11-03","current":-4.019515,"twenty":-9.691209,"median":-4.717575,"eighty":-1.855177,"marketCap":122955935},{"date":"2023-11-10","current":-3.998743,"twenty":-9.691209,"median":-4.717575,"eighty":-1.866555,"marketCap":122320504},{"date":"2023-11-17","current":-3.967584,"twenty":-9.691209,"median":-4.717575,"eighty":-1.884164,"marketCap":121367357},{"date":"2023-11-24","current":-4.102087,"twenty":-9.691209,"median":-4.717575,"eighty":-1.890862,"marketCap":125481774},{"date":"2023-12-01","current":-4.003416,"twenty":-9.691209,"median":-4.717575,"eighty":-1.896783,"marketCap":122463476},{"date":"2023-12-08","current":-4.44951,"twenty":-9.691209,"median":-4.71678,"eighty":-1.914801,"marketCap":136109361},{"date":"2023-12-15","current":-4.079756,"twenty":-9.691209,"median":-4.71678,"eighty":-1.926539,"marketCap":124798686},{"date":"2023-12-22","current":-3.920845,"twenty":-9.691209,"median":-4.71678,"eighty":-1.948939,"marketCap":119937637},{"date":"2023-12-29","current":-4.007571,"twenty":-9.691209,"median":-4.717575,"eighty":-1.962215,"marketCap":122590562},{"date":"2024-01-05","current":-3.806259,"twenty":-9.691209,"median":-4.717575,"eighty":-1.964214,"marketCap":123866756},{"date":"2024-01-12","current":-3.61917,"twenty":-9.691209,"median":-4.717575,"eighty":-1.990725,"marketCap":117778336},{"date":"2024-01-19","current":-3.663622,"twenty":-9.691209,"median":-4.717575,"eighty":-2.007427,"marketCap":119224932},{"date":"2024-01-26","current":-3.190282,"twenty":-9.691209,"median":-4.717575,"eighty":-2.01573,"marketCap":103821070},{"date":"2024-02-02","current":-3.110659,"twenty":-9.691209,"median":-4.717575,"eighty":-2.046637,"marketCap":101229915},{"date":"2024-02-09","current":-2.98805,"twenty":-9.691209,"median":-4.717575,"eighty":-2.062049,"marketCap":97239854},{"date":"2024-02-16","current":-3.509794,"twenty":-9.691209,"median":-4.717575,"eighty":-2.08381,"marketCap":134005534},{"date":"2024-02-23","current":-3.291865,"twenty":-9.691209,"median":-4.717575,"eighty":-2.09593,"marketCap":125684876},{"date":"2024-03-01","current":-3.201442,"twenty":-9.691209,"median":-4.717575,"eighty":-2.100704,"marketCap":122232520},{"date":"2024-03-08","current":-3.10852,"twenty":-9.691209,"median":-4.717575,"eighty":-2.104922,"marketCap":118684706},{"date":"2024-03-15","current":-2.870173,"twenty":-9.691209,"median":-4.717575,"eighty":-2.120049,"marketCap":109584485},{"date":"2024-03-22","current":-3.126438,"twenty":-9.691209,"median":-4.717575,"eighty":-2.128662,"marketCap":119368814},{"date":"2024-03-28","current":-3.433956,"twenty":-9.691209,"median":-4.717575,"eighty":-2.137884,"marketCap":131110009},{"date":"2024-04-05","current":-3.951071,"twenty":-9.691209,"median":-4.717575,"eighty":-2.140205,"marketCap":150853671},{"date":"2024-04-12","current":-3.471875,"twenty":-9.691209,"median":-4.717575,"eighty":-2.156475,"marketCap":132557771},{"date":"2024-04-19","current":-3.356452,"twenty":-9.691209,"median":-4.717575,"eighty":-2.193057,"marketCap":128150846},{"date":"2024-04-26","current":-3.052684,"twenty":-9.691209,"median":-4.717575,"eighty":-2.247618,"marketCap":116552836},{"date":"2024-05-03","current":-3.34281,"twenty":-9.691209,"median":-4.717575,"eighty":-2.301143,"marketCap":127630011},{"date":"2024-05-10","current":-3.314914,"twenty":-9.691209,"median":-4.717575,"eighty":-2.326035,"marketCap":126564924},{"date":"2024-05-17","current":-3.331608,"twenty":-9.691209,"median":-4.717575,"eighty":-2.339642,"marketCap":120599464},{"date":"2024-05-24","current":-3.41496,"twenty":-9.691209,"median":-4.717575,"eighty":-2.342331,"marketCap":123616709},{"date":"2024-05-31","current":-3.272213,"twenty":-9.691209,"median":-4.717575,"eighty":-2.37315,"marketCap":118449451},{"date":"2024-06-07","current":-3.152924,"twenty":-9.691209,"median":-4.717575,"eighty":-2.407393,"marketCap":114131358},{"date":"2024-06-14","current":-3.13246,"twenty":-9.691209,"median":-4.717575,"eighty":-2.450107,"marketCap":113390597},{"date":"2024-06-21","current":-3.196846,"twenty":-9.691209,"median":-4.717575,"eighty":-2.581674,"marketCap":115721283},{"date":"2024-06-28","current":-3.185366,"twenty":-9.729214,"median":-4.723313,"eighty":-2.675783,"marketCap":115305735},{"date":"2024-07-05","current":-2.422715,"twenty":-9.729214,"median":-4.723313,"eighty":-2.724756,"marketCap":87698846},{"date":"2024-07-12","current":-3.854682,"twenty":-9.729214,"median":-4.723313,"eighty":-2.853143,"marketCap":139534032},{"date":"2024-07-15","current":-3.663021,"twenty":-9.729214,"median":-4.723313,"eighty":-2.87934,"marketCap":132596175},{"date":"2024-08-02","current":-4.519007,"twenty":-9.805802,"median":-4.737212,"eighty":-2.987559,"marketCap":163581655},{"date":"2024-08-09","current":-4.442143,"twenty":-9.805802,"median":-4.738775,"eighty":-3.000847,"marketCap":160799285},{"date":"2024-08-16","current":-2.767097,"twenty":-9.805802,"median":-4.738775,"eighty":-3.003636,"marketCap":105959306},{"date":"2024-08-23","current":-2.705743,"twenty":-9.805802,"median":-4.738775,"eighty":-3.004729,"marketCap":103609875},{"date":"2024-08-30","current":-2.674121,"twenty":-9.805802,"median":-4.738775,"eighty":-3.017858,"marketCap":102399015},{"date":"2024-09-06","current":-2.54858,"twenty":-9.805802,"median":-4.738775,"eighty":-3.017858,"marketCap":97591719},{"date":"2024-09-13","current":-2.442389,"twenty":-9.805802,"median":-4.738775,"eighty":-3.017858,"marketCap":93525398},{"date":"2024-09-20","current":-2.586809,"twenty":-9.805802,"median":-4.738775,"eighty":-3.017858,"marketCap":99055595},{"date":"2024-09-27","current":-2.440029,"twenty":-9.805802,"median":-4.738775,"eighty":-3.017858,"marketCap":93435035},{"date":"2024-10-04","current":-2.103051,"twenty":-9.805802,"median":-4.738775,"eighty":-3.017858,"marketCap":80531241},{"date":"2024-10-11","current":-1.888309,"twenty":-9.805802,"median":-4.738775,"eighty":-3.017858,"marketCap":72308235},{"date":"2024-10-18","current":-1.935033,"twenty":-9.805802,"median":-4.738775,"eighty":-3.017858,"marketCap":74097416},{"date":"2024-10-25","current":-1.632979,"twenty":-9.805802,"median":-4.738775,"eighty":-3.017858,"marketCap":62530990},{"date":"2024-10-31","current":-1.910019,"twenty":-9.805802,"median":-4.738775,"eighty":-3.017858,"marketCap":73139572},{"date":"2024-11-08","current":-1.803828,"twenty":-9.808824,"median":-4.740895,"eighty":-3.021332,"marketCap":69073250},{"date":"2024-11-15","current":-1.549914,"twenty":-9.808824,"median":-4.740895,"eighty":-3.021332,"marketCap":59350223},{"date":"2024-11-22","current":-0.832902,"twenty":-9.808824,"median":-4.740895,"eighty":-3.021332,"marketCap":31893953},{"date":"2024-11-29","current":-0.669953,"twenty":-9.808824,"median":-4.740895,"eighty":-3.021332,"marketCap":25654250},{"date":"2024-12-06","current":-0.738563,"twenty":-9.808824,"median":-4.740895,"eighty":-3.021332,"marketCap":28281493},{"date":"2024-12-13","current":-0.577129,"twenty":-9.808824,"median":-4.740895,"eighty":-3.021332,"marketCap":22099746},{"date":"2024-12-20","current":-0.518609,"twenty":-9.808824,"median":-4.740895,"eighty":-3.021332,"marketCap":19858862},{"date":"2024-12-27","current":-0.667936,"twenty":-9.808824,"median":-4.740895,"eighty":-3.021332,"marketCap":25576979},{"date":"2025-01-03","current":-0.766035,"twenty":-9.808824,"median":-4.740895,"eighty":-3.021332,"marketCap":29981702},{"date":"2025-01-10","current":-0.732471,"twenty":-9.811847,"median":-4.743015,"eighty":-3.025732,"marketCap":28668071},{"date":"2025-01-17","current":-0.643627,"twenty":-9.811847,"median":-4.743015,"eighty":-3.025732,"marketCap":25190812},{"date":"2025-01-24","current":-0.691623,"twenty":-9.811847,"median":-4.743015,"eighty":-3.025732,"marketCap":27069313},{"date":"2025-01-31","current":-0.621363,"twenty":-9.811847,"median":-4.743015,"eighty":-3.025732,"marketCap":24319415},{"date":"2025-02-07","current":-0.581841,"twenty":-9.811847,"median":-4.743015,"eighty":-3.025732,"marketCap":22772597},{"date":"2025-02-14","current":-0.59282,"twenty":-9.811847,"median":-4.743015,"eighty":-3.025732,"marketCap":23202269},{"date":"2025-02-21","current":-0.400693,"twenty":-9.811847,"median":-4.743015,"eighty":-3.025732,"marketCap":15897851},{"date":"2025-02-28","current":-0.355209,"twenty":-9.811847,"median":-4.743015,"eighty":-3.025732,"marketCap":14093230},{"date":"2025-03-07","current":-0.385532,"twenty":-9.814869,"median":-4.74328,"eighty":-3.03238,"marketCap":15296310},{"date":"2025-03-14","current":-0.335716,"twenty":-9.814869,"median":-4.74328,"eighty":-3.03238,"marketCap":13319821},{"date":"2025-03-21","current":-0.335716,"twenty":-9.814869,"median":-4.74328,"eighty":-3.03238,"marketCap":13319821},{"date":"2025-03-28","current":-0.281568,"twenty":-9.814869,"median":-4.74328,"eighty":-3.03238,"marketCap":11171462},{"date":"2025-04-04","current":-0.223088,"twenty":-9.814869,"median":-4.74328,"eighty":-3.03238,"marketCap":8851235},{"date":"2025-04-11","current":-0.207927,"twenty":-9.811847,"median":-4.743015,"eighty":-3.025732,"marketCap":8249695},{"date":"2025-04-17","current":-0.214208,"twenty":-9.811847,"median":-4.743015,"eighty":-3.025732,"marketCap":8498905},{"date":"2025-04-25","current":-0.189279,"twenty":-9.814869,"median":-4.74328,"eighty":-3.03238,"marketCap":7509801},{"date":"2025-05-02","current":-0.178796,"twenty":-9.814869,"median":-4.74328,"eighty":-3.03238,"marketCap":7093891},{"date":"2025-05-09","current":-0.1731,"twenty":-9.814869,"median":-4.74328,"eighty":-3.03238,"marketCap":6867909},{"date":"2025-05-16","current":-0.193454,"twenty":-9.814869,"median":-4.74328,"eighty":-3.03238,"marketCap":8134394},{"date":"2025-05-23","current":-0.177182,"twenty":-9.814869,"median":-4.74328,"eighty":-3.03238,"marketCap":7450202},{"date":"2025-05-30","current":-0.172875,"twenty":-9.814869,"median":-4.74328,"eighty":-3.03238,"marketCap":7269092},{"date":"2025-06-06","current":-0.209437,"twenty":-9.814869,"median":-4.74328,"eighty":-3.03238,"marketCap":8806468},{"date":"2025-06-13","current":-0.232678,"twenty":-9.814869,"median":-4.74328,"eighty":-3.03238,"marketCap":9783708},{"date":"2025-06-20","current":-0.242527,"twenty":-9.817891,"median":-4.743545,"eighty":-3.033479,"marketCap":10197817},{"date":"2025-06-27","current":-0.353452,"twenty":-9.817891,"median":-4.743545,"eighty":-3.032105,"marketCap":14862039},{"date":"2025-07-03","current":-0.587315,"twenty":-9.817891,"median":-4.743545,"eighty":-3.004864,"marketCap":24695569},{"date":"2025-07-11","current":-0.433178,"twenty":-9.817891,"median":-4.743545,"eighty":-2.992519,"marketCap":18214379},{"date":"2025-07-18","current":-0.423877,"twenty":-9.817891,"median":-4.743545,"eighty":-2.981211,"marketCap":17823273},{"date":"2025-07-25","current":-0.449123,"twenty":-9.817891,"median":-4.743545,"eighty":-2.913347,"marketCap":18884847},{"date":"2025-08-01","current":-0.364082,"twenty":-9.817891,"median":-4.743545,"eighty":-2.84733,"marketCap":15309018},{"date":"2025-08-08","current":-0.342822,"twenty":-9.817891,"median":-4.743545,"eighty":-2.808158,"marketCap":14415061},{"date":"2025-08-15","current":-0.363557,"twenty":-9.817891,"median":-4.743545,"eighty":-2.744334,"marketCap":14638550},{"date":"2025-08-22","current":-0.519685,"twenty":-9.817891,"median":-4.743545,"eighty":-2.690168,"marketCap":20924994},{"date":"2025-08-29","current":-0.591511,"twenty":-9.817891,"median":-4.743545,"eighty":-2.595776,"marketCap":23817067},{"date":"2025-09-05","current":-0.485884,"twenty":-9.817891,"median":-4.744075,"eighty":-2.546787,"marketCap":19564019},{"date":"2025-09-12","current":-0.507009,"twenty":-9.817891,"median":-4.743545,"eighty":-2.463155,"marketCap":20414629},{"date":"2025-09-19","current":-0.494334,"twenty":-9.817891,"median":-4.743545,"eighty":-2.422715,"marketCap":19904263},{"date":"2025-09-26","current":-0.485884,"twenty":-9.817891,"median":-4.743545,"eighty":-2.362628,"marketCap":19564019},{"date":"2025-10-03","current":-0.561936,"twenty":-9.817891,"median":-4.743545,"eighty":-2.103051,"marketCap":22626214},{"date":"2025-10-10","current":-0.54081,"twenty":-9.817891,"median":-4.743545,"eighty":-1.910019,"marketCap":21775604},{"date":"2025-10-17","current":-0.625312,"twenty":-9.817891,"median":-4.743545,"eighty":-1.842529,"marketCap":25178042},{"date":"2025-10-24","current":-0.726714,"twenty":-9.817891,"median":-4.743545,"eighty":-1.7656,"marketCap":29260968},{"date":"2025-10-31","current":-0.720266,"twenty":-9.817891,"median":-4.743545,"eighty":-1.693862,"marketCap":29001339},{"date":"2025-11-07","current":-0.568872,"twenty":-9.817891,"median":-4.743545,"eighty":-1.637699,"marketCap":22905516},{"date":"2025-11-14","current":-0.463356,"twenty":-9.817891,"median":-4.743545,"eighty":-0.943919,"marketCap":18656912},{"date":"2025-11-21","current":-0.45418,"twenty":-9.817891,"median":-4.743545,"eighty":-0.789726,"marketCap":18287469},{"date":"2025-11-28","current":-0.660626,"twenty":-9.817891,"median":-4.743545,"eighty":-0.768964,"marketCap":26599955},{"date":"2025-12-05","current":-0.57346,"twenty":-9.817891,"median":-4.743545,"eighty":-0.732471,"marketCap":23090238},{"date":"2025-12-12","current":-0.532171,"twenty":-9.817891,"median":-4.743545,"eighty":-0.724557,"marketCap":21427741},{"date":"2025-12-19","current":-0.467943,"twenty":-9.817891,"median":-4.743545,"eighty":-0.710312,"marketCap":18841634},{"date":"2025-12-26","current":-0.444057,"twenty":-9.817891,"median":-4.743545,"eighty":-0.691623,"marketCap":16622791},{"date":"2026-01-02","current":-0.430967,"twenty":-9.817891,"median":-4.743545,"eighty":-0.674998,"marketCap":16132786},{"date":"2026-01-09","current":-0.49919,"twenty":-9.817891,"median":-4.743545,"eighty":-0.669953,"marketCap":18686625},{"date":"2026-01-16","current":-0.475062,"twenty":-9.817891,"median":-4.743545,"eighty":-0.660626,"marketCap":17783438},{"date":"2026-01-23","current":-0.47118,"twenty":-9.817891,"median":-4.743545,"eighty":-0.643627,"marketCap":17638097},{"date":"2026-01-30","current":-0.427085,"twenty":-9.817891,"median":-4.737212,"eighty":-0.628512,"marketCap":15987446},{"date":"2026-02-06","current":-0.394915,"twenty":-9.817891,"median":-4.724748,"eighty":-0.617487,"marketCap":14783196},{"date":"2026-02-13","current":-0.440064,"twenty":-9.817891,"median":-4.715985,"eighty":-0.591511,"marketCap":16473298}],"updateTime":1771277054080},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CTXR\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2611054152","title":"Citius Pharmaceuticals reports first revenue of $3.9 mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2611054152","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611054152?lang=en_us&edition=fundamental","pubTime":"2026-02-13 21:08","pubTimestamp":1770988132,"startTime":"0","endTime":"0","summary":"Citius Pharmaceuticals reports first revenue of $3.9 mlnOverviewBiopharmaceutical firm reported first revenue of $3.9 mln from LYMPHIR launch in Q1 2026Net loss for Q1 2026 was $8.2 mln, with basic EP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nL1N3Z90KS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTXR","BK4007"],"gpt_icon":0},{"id":"2611522871","title":"Citius Oncology Inc. posts Q1 net loss of USD 5.53 million, down 17 percent","url":"https://stock-news.laohu8.com/highlight/detail?id=2611522871","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611522871?lang=en_us&edition=fundamental","pubTime":"2026-02-13 21:02","pubTimestamp":1770987756,"startTime":"0","endTime":"0","summary":"Citius Oncology Inc. reported its financial results for the quarter ended December 31, 2025. The company recorded a net loss of USD 5.53 million for the period, compared to a net loss of USD 6.66 million in the same quarter of the previous year, reflecting a decrease of 17 percent. Revenue commenced in December 2025 following the commercial launch of LYMPHIR , an approved oncology immunotherapy for the treatment of cutaneous T-cell lymphoma, contributing to a gross profit of USD 3.15 million for the quarter. As of December 31, 2025, Citius Oncology had an accumulated deficit of USD 69.57 million. The company noted that it has historically relied on funding from Citius Pharma and recently completed equity offerings, projecting that it and Citius Pharma collectively will have sufficient funds to continue operations through May 2026. Citius Oncology has retained Jefferies LLC as its exclusive financial advisor to evaluate strategic alternatives to maximize shareholder value. The company p","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nNDL2zrf30:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTXR","BK4139","BK4559","BK4127","CTOR","JEF","BK4007"],"gpt_icon":0},{"id":"2611524271","title":"Citius Pharma Q1 stock-based compensation expense rises to USD 3.56 million, up 97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611524271","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611524271?lang=en_us&edition=fundamental","pubTime":"2026-02-13 21:01","pubTimestamp":1770987719,"startTime":"0","endTime":"0","summary":"Citius Pharmaceuticals Inc. reported its earnings for the three months ended December 31, 2025. The company posted interest income of USD 0.05 million for the quarter. Interest expense totaled USD 0.16 million for the same period, primarily attributed to the March 28, 2025 letter agreement with Eisai and the note payable, including the fair value of the warrant issued to the lender. Stock-based compensation expense for the quarter increased by USD 1.76 million, mainly due to Citius Oncology restricted stock awards granted in September 2025. During the period, Citius Pharmaceuticals continued its focus on the development and commercialization of first-in-class critical care products. The company highlighted its obligations related to Citius Oncology, including milestone payments and tiered royalties to Dr. Reddy’s, as well as provisions for sublicensing revenue sharing. The company also noted the dissolution of Citius Pharmaceuticals, LLC in December 2023 and ongoing investments from pr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nNDL4T3W5G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","CTOR","CTXR"],"gpt_icon":0},{"id":"2611521021","title":"Citius Pharmaceuticals Q1 Basic EPS USD -0.38","url":"https://stock-news.laohu8.com/highlight/detail?id=2611521021","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611521021?lang=en_us&edition=fundamental","pubTime":"2026-02-13 21:00","pubTimestamp":1770987601,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nPLX03D775:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CTXR"],"gpt_icon":0},{"id":"2610301579","title":"Citius Oncology Signs Exclusive Distribution Agreement With Uniphar for LYMPHIR in Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2610301579","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610301579?lang=en_us&edition=fundamental","pubTime":"2026-02-11 21:14","pubTimestamp":1770815656,"startTime":"0","endTime":"0","summary":"Citius Oncology Inc. announced it has entered into an exclusive distribution agreement with Uniphar, an international healthcare services company, to support access to LYMPHIR  outside the United States. Under the agreement, Uniphar will act as the exclusive distribution partner for LYMPHIR in designated territories across Western and Eastern Europe through country-specific managed access programs, subject to local regulations. This marks the third international distribution partnership for Citius Oncology as part of its global expansion strategy. LYMPHIR is not approved for commercial use outside the United States and will be provided in these territories only through managed access programs, which do not constitute marketing authorization or a commercial launch.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nNDLKN0ZF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTOR","CTXR","BK4139","BK4007"],"gpt_icon":0},{"id":"2610004937","title":"Citius Oncology Expands International Distribution of Lymphir™ to European Union Through Exclusive Agreement With Uniphar","url":"https://stock-news.laohu8.com/highlight/detail?id=2610004937","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610004937?lang=en_us&edition=fundamental","pubTime":"2026-02-11 21:00","pubTimestamp":1770814805,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nTUA4QGQJT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTOR","CTXR","BK4139","BK4007"],"gpt_icon":0},{"id":"2607516260","title":"Citius Oncology Inc. Files Information Statement Detailing Authorized Corporate Actions","url":"https://stock-news.laohu8.com/highlight/detail?id=2607516260","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607516260?lang=en_us&edition=fundamental","pubTime":"2026-01-30 05:31","pubTimestamp":1769722261,"startTime":"0","endTime":"0","summary":"Citius Oncology Inc. has announced that its shareholders authorized certain corporate actions by written consent as of January 20, 2026. The company’s Board of Directors has informed stockholders of these approved actions. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Citius Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 29, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nNDL3pFqY2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTOR","BK4139","BK4007","CTXR"],"gpt_icon":0},{"id":"2605214191","title":"Citius Oncology Inc. Files Draft Information Statement Outlining Authorized Corporate Actions","url":"https://stock-news.laohu8.com/highlight/detail?id=2605214191","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605214191?lang=en_us&edition=fundamental","pubTime":"2026-01-21 05:31","pubTimestamp":1768944706,"startTime":"0","endTime":"0","summary":"Citius Oncology Inc. has announced that its shareholders have authorized certain corporate actions as of January 20, 2026. The company provided an information statement to update shareholders regarding the approved actions. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Citius Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 20, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nNDL1qsW0L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CTXR","BK4007","CTOR"],"gpt_icon":0},{"id":"2593403318","title":"Dow Gains Over 100 Points; US Jobless Claims Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2593403318","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593403318?lang=en_us&edition=fundamental","pubTime":"2025-12-24 23:27","pubTimestamp":1766590067,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"73197d9df2f4cf43e87414d936fef4c7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/25/12/49583720/dow-gains-over-100-points-us-jobless-claims-decline","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USAW.SI","TQQQ","CTXR",".IXIC","SQQQ","QID","TSYW.SI","BK4007","USJW.SI","MNQmain","SOBR","NVIW.SI","MWG","BK4157","NQmain","BK4170","PCOM","BK4020","OMER","BK4104","BK4122","SONM","PSQ","PCLA","QLD"],"gpt_icon":1},{"id":"2593443797","title":"Citius Pharma Q4 EPS $(0.11) Beats $(0.43) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2593443797","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593443797?lang=en_us&edition=fundamental","pubTime":"2025-12-24 05:36","pubTimestamp":1766525795,"startTime":"0","endTime":"0","summary":"Citius Pharma (NASDAQ:CTXR) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.43) by 74.42 percent. This is a 93.6 percent increase over losses of $(1.72) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/12/49574854/citius-pharma-q4-eps-0-11-beats-0-43-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Citius Pharma Q4 EPS $(0.11) Beats $(0.43) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTXR","BK4007"],"gpt_icon":0},{"id":"2593443440","title":"Press Release: Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2593443440","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593443440?lang=en_us&edition=fundamental","pubTime":"2025-12-24 05:30","pubTimestamp":1766525400,"startTime":"0","endTime":"0","summary":"Subsidiary, Citius Oncology, launches cancer immunotherapy, LYMPHIR, in the U.S. in December 2025. CRANFORD, N.J., Dec. 23, 2025 /PRNewswire/ -- Citius Pharmaceuticals, Inc.  , a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products today reported business and financial results for the fiscal year ended September 30, 2025.\"2025 was a pivotal year for Citius as we successfully launched LYMPHIR following its FDA approval, marking the first new systemic therapy for cutaneous T-cell lymphoma  patients since 2018. This milestone reflects our ability to execute and our commitment to delivering impactful treatments for patients with limited options,\" said Leonard Mazur, Chairman and CEO of Citius Pharma. \"With LYMPHIR commercially available as of December 2025, we are focused on its successful launch and adoption in 2026, with even greater opportunities ahead to drive value for patients and shareholders. We are actively engaging ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4555","CTXR","BK4232","BK4585","BK4007","BK4588","BK4604","R","03160","TM","BK4099","BK4022"],"gpt_icon":0},{"id":"2593443641","title":"Citius Oncology posts FY cash balance of USD 3.9 million and accumulated deficit of USD 64.0 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2593443641","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593443641?lang=en_us&edition=fundamental","pubTime":"2025-12-24 05:22","pubTimestamp":1766524929,"startTime":"0","endTime":"0","summary":"Citius Oncology Inc. reported its full year  financial results for the period ending September 30, 2025. The company posted an accumulated deficit of USD 64.0 million and had no revenue for the period. As of September 30, 2025, Citius Oncology Inc. reported cash holdings of USD 3.9 million and a negative working capital of approximately USD 21.9 million. During the fiscal year, the company raised net proceeds of approximately USD 15 million from equity offerings. Citius Pharma, the parent company, also raised net proceeds of approximately USD 32 million from equity offerings and USD 1 million from a note payable.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Citius Oncology Inc. published the original content used to generate this new","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nNDL1Jb4W6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTXR","BK4139","CTOR","BK4007"],"gpt_icon":0},{"id":"2590565455","title":"Citius Oncology Announces Warrant and Share Issuance in $18 Million Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2590565455","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590565455?lang=en_us&edition=fundamental","pubTime":"2025-12-11 06:29","pubTimestamp":1765405785,"startTime":"0","endTime":"0","summary":"Citius Oncology Inc. has announced agreements involving the issuance of warrants and share rights as part of an $18 million concurrent registered direct offering and private placement. The company will issue unregistered warrants to purchase up to 1,284,404 shares of common stock at $1.09 per share in the registered direct offering, and additional warrants to purchase up to 15,229,358 shares of common stock at $1.09 per share in a private placement. The exercise of these warrants is contingent on stockholder approval and they will expire five years from the date of such approval. Additionally, Citius Oncology will amend previously issued warrants, reducing their exercise price to $1.09 per share, effective upon closing of the offerings. Proceeds will support the commercial launch of LYMPHIR, a cancer immunotherapy for cutaneous T-cell lymphoma.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nNDL4PPKCz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTXR","BK4139","CTOR","BK4007"],"gpt_icon":0},{"id":"2590341455","title":"Citius Oncology Sells Shares and Warrants in $18 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2590341455","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590341455?lang=en_us&edition=fundamental","pubTime":"2025-12-09 21:45","pubTimestamp":1765287915,"startTime":"0","endTime":"0","summary":"Citius Oncology Inc. has announced a private placement involving the sale of shares of its common stock, pre-funded warrants, and warrants to a single healthcare-focused investor. These securities, along with unregistered warrants to purchase additional shares, are being offered in a private placement under Section 4 of the Securities Act and/or Regulation D. The shares and warrants sold in the private placement have not been registered under the Securities Act or state securities laws and can only be resold under an effective registration statement or an applicable exemption. The company has agreed to file a registration statement with the SEC to cover the resale of these securities.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Citi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nNDL684HsL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTOR","CTXR","BK4139","BK4007"],"gpt_icon":0},{"id":"2590842341","title":"Citius Oncology Inc - Proceeds Support Launch of Lymphir for Cutaneous T-Cell Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2590842341","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590842341?lang=en_us&edition=fundamental","pubTime":"2025-12-09 21:30","pubTimestamp":1765287003,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nTUAJB85X:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CTXR","BK4007","CTOR"],"gpt_icon":0},{"id":"2590341358","title":"Citius Oncology Inc - to Purchase 1,284,404 Shares of Common Stock at $1.09 per Share in Direct Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2590341358","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590341358?lang=en_us&edition=fundamental","pubTime":"2025-12-09 21:30","pubTimestamp":1765287003,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nTUAJB85X:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTXR","CTOR","BK4007","BK4139"],"gpt_icon":0},{"id":"2588887889","title":"BRIEF-Citius Oncology Expands Lymphir Distribution To Turkey And Middle East Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2588887889","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588887889?lang=en_us&edition=fundamental","pubTime":"2025-12-04 21:44","pubTimestamp":1764855868,"startTime":"0","endTime":"0","summary":"BRIEF-Citius Oncology Expands Lymphir Distribution To Turkey And Middle East Countries Dec 4 (Reuters) - Citius Oncology Inc CTOR.O:CITIUS ONCOLOGY EXPANDS LYMPHIR DISTRIBUTION TO TURKEY AND MIDDLE EA","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nTUA8B8B6C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTXR","BK4139","BK4007","CTOR"],"gpt_icon":0},{"id":"2588882226","title":"Citius Oncology Expands Lymphir™ Distribution to Turkey and Middle East Countries Through Exclusive Agreement With Er-Kim","url":"https://stock-news.laohu8.com/highlight/detail?id=2588882226","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588882226?lang=en_us&edition=fundamental","pubTime":"2025-12-04 21:37","pubTimestamp":1764855420,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nTUA8B8B6C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CTOR","BK4139","CTXR"],"gpt_icon":0},{"id":"2588970586","title":"Citius Pharmaceuticals Highlights Oncology Pipeline and LYMPHIR Launch in New Corporate Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2588970586","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588970586?lang=en_us&edition=fundamental","pubTime":"2025-12-02 05:42","pubTimestamp":1764625336,"startTime":"0","endTime":"0","summary":"Citius Pharmaceuticals Inc. has provided an update on its advanced development programs in the biopharmaceutical sector. The company highlighted the launch of LYMPHIR  in December 2025 for the treatment of adult patients with relapsed or refractory Stage I-III cutaneous T-cell lymphoma  after at least one prior systemic therapy. LYMPHIR is the first marketed product by Citius Oncology, Inc. , which became a stand-alone public company in August 2024 and remains a majority-owned subsidiary of Citius Pharmaceuticals. Other programs featured include Mino-Lok, a treatment designed to salvage infected catheters causing central line-associated bloodstream infections , which has completed a Phase 3 trial with positive topline data, and Halo-Lido, a prescription therapy in development for hemorrhoids, which has completed a Phase 2b trial. The presentation notes that Citius Oncology has established a shared management services agreement with Citius Pharmaceuticals to support operational efficien","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDL2Ff77C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CTOR","BK4007","CTXR"],"gpt_icon":0},{"id":"2588120774","title":"Citius Oncology Announces U.S. Commercial Launch of Lymphir™, a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (Ctcl)","url":"https://stock-news.laohu8.com/highlight/detail?id=2588120774","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588120774?lang=en_us&edition=fundamental","pubTime":"2025-12-02 01:00","pubTimestamp":1764608401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nTUA78MRJT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTOR","CTXR","BK4007","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":35,"code":"91000000","status":"200"}]}}